Read more from Author Ben Oakley here: https://globelivemedia.com/author/ben-oakley/
Brasilia, Jan 17 2021 – The Brazilian health regulator (Anvisa) approved on Sunday the emergency use of the Chinese CoronaVac vaccine and the British AstraZeneca / Oxford against covid-19, the first to obtain the green light in this country that already accumulates almost 210,000 deaths. The five directors of Anvisa spoke in favor of authorizing the vaccines, opening the door for Brazil to start its vaccination campaign with CoronaVac, produced by the Chinese firm Sinovac in association with the Brazilian Instituto Butantan (del state of Sao Paulo), the only one of the two immunizers already available in the national territory.
Health Minister Eduardo Pazuello called a press conference at the end of the Anvisa meeting to announce details about the immunization plan, the start date of which has not yet been defined. The approval occurs amid a resurgence of the disease, with daily balances of more than 1,000 deaths in the country and a dramatic situation in Manaus, the capital of the state of Amazonas (north), with reports of deaths of people due to lack of oxygen It also has as a backdrop a tug-of-war between President Jair Bolsonaro and Sao Paulo Governor Joao Doria, who are fighting for the lead in the start of the vaccination campaign in this country of 212 million inhabitants.
Doria welcomed Anvisa’s decision and announced that it will immediately deliver the 6 million doses of CoronaVac included in the request for authorization to the Ministry of Health for distribution to all Brazilian states. However, some media indicated that the governor plans to order the administration of the first dose from all over Brazil this same Sunday, in Sao Paulo.
Ben Oakley is the guy you can really trust when it comes to Mainstream News. Whether it is something happening at the Wall Street of New York City or inside the White House in Washington, D.C., no one can cover mainstream news like Ben. Get a daily dose of Trustworthy News by Ben Oakley, only at Globe Live Media.